Isothermal amplification produces nucleic-acid products at a largely constant reaction temperature. LAMP uses a strand-displacing polymerase and multiple primers, while recombinase-based amplification uses recombinase, single-strand DNA-binding proteins, and a strand-displacing polymerase. Rolling-circle and multiple-displacement approaches have different template and primer requirements.
Strand displacement, not simply polymerase activity, is central to many isothermal methods. LAMP commonly operates with a Bst-family polymerase and a coordinated primer set. Recombinase-based systems use ATP-dependent presynaptic filament formation and target invasion. Phi29-type enzymes support highly processive displacement synthesis but are not interchangeable with LAMP polymerases.
Creative Enzymes supplies Bst-family polymerases, T4 UvsX Recombinase, UvsY, SSB proteins, phi29 polymerase, warm-start reverse transcriptase, and glycerol-free options. Custom support is available through our isothermal amplification reagent development service.
Figure 1. Principles of representative enzyme‐mediated isothermal amplification technologies. (A) Schematic of LAMP. (B) Schematic illustration of SDA reaction cycle. (C) Diagram of EXPAR. (D) Schematic of RCA. (Hou et al., 2026)
Strand displacement, not simply polymerase activity, is central to many isothermal methods. LAMP commonly operates with a Bst-family polymerase and a coordinated primer set. Recombinase-based systems use ATP-dependent presynaptic filament formation and target invasion. Phi29-type enzymes support highly processive displacement synthesis but are not interchangeable with LAMP polymerases.
Isothermal amplification produces nucleic-acid products at a largely constant reaction temperature. LAMP uses a strand-displacing polymerase and multiple primers, while recombinase-based amplification uses recombinase, single-strand DNA-binding proteins, and a strand-displacing polymerase. Rolling-circle and multiple-displacement approaches have different template and primer requirements. The relevant enzyme must be evaluated in the complete sample-to-result workflow because cofactors, carryover from upstream steps, target abundance, temperature, reaction time, and detection chemistry can change apparent performance.
Product selection should begin with the complete reaction and workflow rather than an isolated activity value. The following components represent practical roles that may be evaluated for isothermal amplification enzymes and mixes development.
| Enzyme or Reagent | Role in the Workflow | Representative Product or Support | Selection Considerations |
|---|---|---|---|
| Bst DNA polymerase | LAMP and other strand-displacement amplification | Bst DNA Polymerase Large Fragment | Temperature, displacement rate, reverse-transcription tolerance and background |
| Glycerol-free Bst polymerase | Dry-format isothermal formulation | Bst II Pro, Glycerol-free | Drying recovery, reconstitution and storage stability |
| Recombinase | Primer-target pairing in recombinase-based amplification | T4 UvsX Recombinase | ATP system, mediator proteins and nonspecific amplification |
| Warm-start RT | RNA conversion in RT-LAMP | Reverse Transcriptase III WarmStart | Low-temperature control and Bst compatibility |
| Phi29 polymerase | Rolling-circle or multiple-displacement workflows | Pilot phi29 DNA Polymerase | Template topology, primer design, displacement and branching |
LAMP relies on a strand-displacing polymerase and a coordinated set of primers that create self-priming structures. Its high product yield can support fluorescence, turbidity, color, or lateral-flow readouts, but complex primer interactions also create background risk. Recombinase-based amplification uses recombinase-assisted primer invasion, accessory proteins, single-strand binding activity, ATP chemistry, and polymerase extension at a lower temperature. Rolling-circle and multiple-displacement methods use different template topology and priming rules.
These systems should not be combined by treating all strand-displacement enzymes as equivalent. Bst-family variants differ in operating temperature, speed, inhibitor tolerance, reverse-transcription capability, and background behavior. Recombinase systems are sensitive to protein ratios, ATP regeneration, crowding conditions, and primer design. Phi29-type polymerases offer high processivity and strong displacement, but branching amplification and nonspecific priming can complicate diagnostic interpretation.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
In isothermal assays, target and background products can both accumulate without the reset imposed by thermal cycling. A positive result should therefore be defined within a predetermined reading window. Extending incubation until a negative control becomes positive invalidates the distinction rather than increasing sensitivity. Primer screening should include no-template reactions, near-neighbor templates, background nucleic acid, and realistic sample matrices across multiple runs.
For LAMP, primer purity, complementarity, loop-primer concentration, magnesium, dNTPs, betaine or other additives, and temperature influence both speed and nonspecific signal. Melt or annealing analysis can help characterize products when supported by the instrument, but it does not replace identity confirmation during development. In colorimetric assays, sample buffering and reaction acidification can alter the readout independently of target amplification; fluorescence or orthogonal product analysis can separate these effects.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
RT-LAMP adds reverse transcription to the isothermal system. The RT and polymerase must share temperature, salt, magnesium, and additive conditions, and the RNA must remain intact during setup. Warm-start control can limit undesired activity before incubation. A one-pot design may reduce handling, but it also makes it harder to distinguish poor RNA conversion from weak displacement amplification unless module-specific controls are included.
Point-of-care implementation adds heater accuracy, evaporation, reconstitution, operator timing, and visual or reader-based interpretation. A reaction developed in a laboratory block may behave differently in a small cartridge with slow warm-up or temperature gradients. Dry formats must preserve every enzyme and reporter, not only the polymerase. Robustness testing should include device lots, fill volumes, environmental temperatures, sample volumes, and the full time window for result interpretation.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
A fast amplification reaction is useful only when the signal can be interpreted consistently. Fluorescent intercalating dyes may respond to intended and unintended double-stranded products, sequence-specific probes add another recognition layer, and pH-based color changes depend on buffer capacity as well as nucleotide incorporation. Turbidity and lateral-flow formats have their own thresholds and timing constraints. During development, at least one orthogonal product-identity method should be used to show that the reported signal follows the intended target. The final format should then be challenged at the earliest and latest valid reading times.
Document the following elements:
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Potential risks to evaluate include:
Relevant challenge levels and acceptance criteria depend on the intended use, sample matrix, reaction format, instrument, and decision threshold. Performance should be established with the final formulation rather than inferred from individual-component specifications.
Troubleshooting isothermal amplification enzymes and mixes is most efficient when the workflow is divided into sample preparation, enzyme reaction, signal generation, and result interpretation. A positive control and a negative control are necessary, but they may not identify which module failed. Orthogonal measurements and module-specific controls should be selected before changing multiple reagents at once.
| Observation | Possible Causes | Focused Checks |
|---|---|---|
| Negative controls become positive late | Primer-driven background or carryover | Set a valid reading time, inspect products, redesign primers, and use closed-tube controls |
| Slow target reaction | Weak displacement, target structure, or temperature mismatch | Compare polymerase variants, temperature, magnesium, primer sets, and target accessibility |
| Color changes without amplification | Sample buffering or nonspecific chemical response | Confirm amplification by fluorescence or product analysis and control sample pH |
| Dry mix has variable time-to-result | Incomplete dissolution or differential component recovery | Measure reconstitution, mixing, moisture, enzyme recovery, and device heating |
A single successful repeat does not confirm the cause of a failure. Once a likely factor is identified, the proposed correction should be challenged across target levels, representative matrices, reagent lots, instruments or devices, operators, and relevant environmental conditions. The final procedure should define valid controls, acceptance criteria, and actions for invalid runs.
Need Help Selecting Isothermal Amplification Enzymes and Mixes?
Share your target, sample type, workflow, detection chemistry, instrument, desired reagent format, current formulation, performance goals, and expected scale with our technical team.
Request Product Selection Support
Q1. Is isothermal amplification one method?
Q2. Why is strand displacement important?
Q3. Can Bst polymerase be replaced by Taq polymerase?
Q4. What is needed for RNA targets?
Q5. Why can false positives appear late?
Q6. Can mixes be lyophilized?
